https://www.selleckchem.com/pr....oducts/gf109203x.htm
54%) hvKP isolates became sensitive to the drug. The Curaq also inhibited the AcrAB-TolC efflux system at 1 µg/mL concentration by disrupting the membrane potential and causing depolarisation. The kinetic parameters obtained also indicated its promise as a carbapenemase inhibitor. These results suggest that Curaq can be an excellent drug candidate as a broad-spectrum antibacterial and anti-efflux agent.Integrins have been extensively investigated as therapeutic targets over the last decades, which has been inspired by their multiple f
Like
Comment
Share
